04 December 2017 : Clinical Research
High-Frequency Color Doppler Ultrasound in Diagnosis, Treatment, and Rehabilitation of Achilles Tendon Injury
Wen Liu1BCE, Haiying Zhuang2BF, Dazhang Shao3D, Liangliang Wang4D, Miao Shi3AEF*DOI: 10.12659/MSM.904186
Med Sci Monit 2017; 23:5752-5759
Abstract
BACKGROUND: This study evaluated the clinical application of high-frequency color Doppler ultrasonography (HFCDU) in the diagnosis, treatment, and rehabilitation of Achilles tendon injury.
MATERIAL AND METHODS: A total of 68 patients with suspected Achilles tendon injury were examined by HFCDU. There were 42 Achilles tendon injury patients who underwent surgery, and they were randomly divided into a routine treatment group (n=21) and a rehabilitation group (n=21). HFCDU was performed at weeks 1, 3, 6, and 9, and months 3, 6, 9, 12, and 24 after the operation. The thickness of the injured Achilles tendon, echo, blood flow, and tissue adhesion were compared to those of the uninjured side.
RESULTS: Of the 68 patients, 14 had normal ultrasound presentation with strong echo; 7 had laceration, presenting as swelling and decreased echo; 26 had partial tear, presenting as discontinued rupture with no or low echo; 19 had complete rupture, presenting as discontinued fibers with hypoechoic hemorrhage and hyperechoic fat tissue between ends; 1 had plantar tendon rupture and periapical hemorrhage; and 1 had acute Achilles tendonitis. The postoperative tendon thickness decreased over time, echo turned homogeneous, blood flow and adhesions decreased, and these results were consistent with clinical symptoms. Patient condition and ultrasound recovery were better in the rehabilitation group, and the diameter of the injured tendon increased compared with the uninjured side.
CONCLUSIONS: HFCDU can determine the types and extent of tendon injuries, and can help in the diagnosis, treatment, and rehabilitation of Achilles tendon injury.
Keywords: Diagnosis, Rehabilitation, Ultrasonography, Doppler
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952